AGLE - Aeglea Biotherapeutics announces name change to Spyre Therapeutics
2023-11-27 08:59:20 ET
More on Aeglea BioTherapeutics
- Aeglea BioTherapeutics announces 1-for-25 reverse stock split
- Aeglea BioTherapeutics appoints Burrows as CFO, King-Jones as CLO
- Seeking Alpha’s Quant Rating on Aeglea BioTherapeutics
For further details see:
Aeglea Biotherapeutics announces name change to Spyre Therapeutics